RCHOP和RCDOP方案治疗弥漫大B细胞淋巴瘤后间质性肺炎发生率的研究

OBJECTIVE: To identify the risk factors and clinical features associated with the interstitial pneumonia in diffuse large B-cell lymphoma（DLBCL）patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone（RCHOP）or rituximab, cyclophosphamide, liposomal doxorubicin, vinc...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2019
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342673/
https://www.ncbi.nlm.nih.gov/pubmed/32023732
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.12.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342673/
https://www.ncbi.nlm.nih.gov/pubmed/32023732
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.12.008

Ejemplares similares